Femtosecond to replace microkeratome

Article

Dr Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, conducted a survey on the advantages and limitations of femtosecond lasers, and concluded that they will come to replace microkeratomes fully.

Dr Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, conducted a survey on the advantages and limitations of femtosecond lasers, and concluded that they will come to replace microkeratomes fully.

Dr Grabner - who uses the the Intralase (AMO) and the VisuMax (Carl Zeiss Meditec), and has not used microkeratomes for three years - noted the high cost of acquiring and maintaining modern surgical lasers, although the difference between the two machines in operating performance and technical specification, in terms of central wavelength and repetition rate, is not significant.

Femtosecond lasers also offer selectable cutting depth and are computer controlled; treatment times, spot size and surface quality were similar for all the femtoseconds Dr Grabner assessed, although IOP increases varied.

In future, Dr Grabner believes that, to truly rival the microkeratome, femtosecond lasers must evolve to offer a wider range of cuts for PKP and LKP, channels, along with pockets and options for astigmatic KT.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.